Mehrotra M

No ORCID on file · 3 papers in corpus
2023
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13040713

Epithelial ovarian cancer (EOC) is the deadliest gynaecological malignancy and the eighth most prevalent cancer in women, with an abysmal mortality rate of two million worldwide. The existence of multiple overlapping symptoms with other gas…

article 2021
A 24 year-old patient with no prior history of endometriosis diagnosed with bilateral ovarian endometrioid adenocarcinoma arising in endometriosis
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100718
2019
Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc ·doi:10.1038/s41379-018-0158-8

There is currently no blood-based marker in routine use for endometrial cancer patients. Such a marker could potentially be used for early detection, but it could also help to track tumor recurrence following hysterectomy. This is important…